These results demonstrated that the IDET‐mediated activation of the p62‐Keap1‐Nrf2 signaling pathway increases ROS levels in thyroid cancer cells and results in the oxidative stress–induced inhibition of cell proliferation and enhanced sensitivity to taxol. Here, NFE2L2 is linked to thyroid gland carcinoma.